Loading...
OTCM
INND
Market cap861kUSD
Jul 09, Last price  
0.00USD
1D
0.00%
1Q
-75.00%
IPO
-100.00%
Name

InnerScope Hearing Technologies, Inc.

Chart & Performance

D1W1MN
OTCM:INND chart
P/E
P/S
24.83
EPS
Div Yield, %
Shrs. gr., 5y
111.23%
Rev. gr., 5y
-26.89%
Revenues
35k
-72.75%
445,932678,399872,3291,897,688470,626324,876847,109166,111-3,76415,284,3273,694,690127,29534,694
Net income
-175k
L
-77,977-39,21270,85369,744-1,913,332-4,585,117-7,924,339-4,953,69234,3665,575,892-10,975,1505,235,005-174,652
CFO
-169k
L-49.41%
81,970-93,02370,895425,761-589,945-1,165,526-2,925,941-523,534-3,298,977-5,303,158-3,627,400-333,129-168,514

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

InnerScope Hearing Technologies, Inc. specializes in delivering a variety of hearing solutions, primarily supplying the retail hearing aid community with its array of hearing aids and personal sound amplification devices, available in both hearable and wearable forms. The company's operations encompass the manufacturing and direct-to-consumer distribution and sales of these devices. Beyond hardware, InnerScope also offers a suite of related products and services, which include hearing-related therapeutic treatments, physician-developed dietary supplements aimed at supporting hearing health, and a unique CBD oil specifically formulated for managing tinnitus. Expanding its comprehensive approach, InnerScope manages and operates eleven audiological and retail hearing device clinics. Additionally, it provides a business-to-business (B2B) software-as-a-service (SaaS) platform for patient management. Founded in 2012 as Innerscope Advertising Agency, Inc., the company officially adopted its current name, InnerScope Hearing Technologies, Inc., in August 2017, and its corporate headquarters are located in Roseville, California.
IPO date
Jan 24, 2017
Employees
26
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT